Investment Instruments

Professor turned portfolio manager warns of misleading P/E ratios, bank earnings and Fed insolvency in "overvalued, overbullish markets."

One single claimant of the retirement health tool has amassed $1.7 million in paid benefits, according to the AALTCI.

Speculation surrounding industry giant Aviva's potential departure from the U.S. annuity business has prompted competitors to prepare to fill the void.

Many companies and advisors are worried that their clients will view the newly disclosed fees to be too high. It's time to educate participants.

IRI Joins nearly 30 other financial services groups in written testimony to the House Ways and Means Committee, asking for support of retirement tax benefits.

Its a new world when it comes to baking alternative investments into variable-annuity contracts, experts say.